Eczema and race as combined determinants for differential response to step-up asthma therapy.
Department of Pediatrics, National Jewish Health and University of Colorado Denver School of Medicine, Denver, Colo; Pediatric Associates, Lauderdale Lakes, Fla.
Jonathan
J
Malka
Department of Health Evaluation Sciences, Pennsylvania State University, Hershey, Pa.
David T
DT
Mauger
Department of Pediatrics, National Jewish Health and University of Colorado Denver School of Medicine, Denver, Colo.
Ronina
R
Covar
Department of Pediatrics, National Jewish Health and University of Colorado Denver School of Medicine, Denver, Colo.
Nathan
N
Rabinovitch
University of Wisconsin School of Medicine and Public Health, Madison, Wis.
Robert F
RF
Lemanske
Department of Pediatrics, National Jewish Health and University of Colorado Denver School of Medicine, Denver, Colo.
Joseph D
JD
Spahn
Division of Allergy, Immunology, and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine, St Louis, Wash.
Robert C
RC
Strunk
Department of Allergy, Kaiser Permanente and the Department of Pediatrics, University of California-San Diego, San Diego, Calif.
Robert S
RS
Zeiger
Arizona Respiratory Center, University of Arizona, Tucson, Ariz.
Wayne J
WJ
Morgan
Department of Pediatrics, National Jewish Health and University of Colorado Denver School of Medicine, Denver, Colo. Electronic address: szeflers@njhealth.org.
Stanley J
SJ
Szefler
D000085:Acetates / Q000627:therapeutic use*; D000293:Adolescent; D001741:Black or African American; D000420:Albuterol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000730:Androstadienes / Q000627:therapeutic use*; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000150:complications / Q000188:drug therapy* / Q000208:ethnology / Q000473:pathology; D002648:Child; D018592:Cross-Over Studies; D003521:Cyclopropanes; D004338:Drug Combinations; D016903:Drug Monitoring; D004485:Eczema / Q000150:complications / Q000188:drug therapy* / Q000208:ethnology / Q000473:pathology; D005260:Female; D000068298:Fluticasone; D000068297:Fluticasone-Salmeterol Drug Combination; D006630:Hispanic or Latino; D006801:Humans; D008297:Male; D011804:Quinolines / Q000627:therapeutic use*; D013440:Sulfides; D044465:White People
D000085:Acetates; D000730:Androstadienes; D018927:Anti-Asthmatic Agents; D003521:Cyclopropanes; D004338:Drug Combinations; D000068297:Fluticasone-Salmeterol Drug Combination; D011804:Quinolines; D013440:Sulfides; D000068298:Fluticasone; C093875:montelukast; D000420:Albuterol